← All diseases Rare and hereditary disorders

Epidermolysis bullosa

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchMost rigorous evidence only (52)Treatment guideline (7)Meta-analysis (4)Systematic review (18)Phase 3 Study (15)Randomized trial (8)Clinical trial (147)Review article (153)Early study (phase 1 or 2) (20)Single patient description (248)Laboratory or animal research (18)Commentary or editorial (88)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1208)

• Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study. (2020/06/01) ♡
• Analysis of KRT5 and KRT14 gene mutations and mode of inheritance in Iranian patients with clinical suspicion of Epidermolysis bullosa simplex. (2020/05/04) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. STAT3 targeting in dystrophic epidermolysis bullosa. (2020/05/01) ♡
• Living with epidermolysis bullosa: Daily challenges and health-care needs. (2020/04/01) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Skin fragility caused by biallelic KRT10 mutations: an intriguing form of self-improving epidermolytic ichthyosis. (2020/03/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Foot care in epidermolysis bullosa: evidence-based guideline. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Epidermolysis bullosa: diagnostic guidelines in the laboratory setting. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Tumour serine proteases C1r and C1s as novel biomarkers and therapeutic targets in invasive sporadic and recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma. (2020/03/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The psychological functioning of children with epidermolysis bullosa and its relationship with specific aspects of disease. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. International pilot tests of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Efficacy of intravenous immunoglobulins for laryngopharyngeal lesions and upper airway obstruction in epidermolysis bullosa acquisita. (2020/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Podiatrists gaining a foothold. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Verruciform xanthoma in a patient with recessive dystrophic epidermolysis bullosa: Case report and literature review. (2020/03/01) ♡
• Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs. (2020/02/01) ♡
• Surgical management of hand deformities in patients with recessive dystrophic epidermolysis bullosa. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amino acid charge and epidermolysis bullosa simplex severity: genotype-phenotype correlations. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Absent Skin and Butterfly Children: A Sporadic Case of Bart Syndrome. (2020/02/01) ♡
• Flightless I, a contributing factor to skin blistering in Kindler syndrome patients? (2020/02/01) ♡
• Association of dystrophic epidermolysis bullosa and neuroblastoma in a newborn. (2020/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management. (2020/02/01) ♡
• Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita. (2020/01/14) ♡
• Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras. (2020/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Verruciform xanthoma in recessive dystrophic epidermolysis bullosa and keratitis-ichthyosis-deafness syndrome: Report of two cases and a review of the literature. (2020/01/01) ♡
• Previously Unreported COL7A1 Mutation in a Somali Patient with Dystrophic Epidermolysis Bullosa. (2020/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa (2020-10-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (2020-09-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB (2020-08-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa (2020-06-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa (2020-04-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gentamicin for Junctional Epidermolysis Bullosa (2020-04-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients (2020-03-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa (2020-02-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) (2020-02-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa (2020-01-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa (2020-01-03) ♡
• CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. (2019/12/26) ♡
• Toward treatment and cure of epidermolysis bullosa. (2019/12/26) ♡
• From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). (2019/12/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The use of high-flow nasal oxygen during airway management in a child with epidermolysis bullosa dystrophica and a difficult airway. (2019/12/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Epidermolysis Bullosa Acquisita: A Case Report of a Rare Clinical Phenotype and a Review of Literature. (2019/12/15) ♡
• Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa. (2019/12/06) ♡
• Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination. (2019/12/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Extensive Epidermal Skin Loss Secondary to HSV Type One: Neonatal Management Challenges. (2019/12/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa. (2019/12/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nursing care of a newborn with epidermolysis bullosa: a case report. (2019/12/02) ♡
• Intrabullous injection: A novel, painless technique of drug delivery in localized bullous dermatoses. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reversion for correction: fibroblasts to the rescue! (2019/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.